Skip to main content
. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793

Table 1.

Patient characteristics. Values are numbers (percentages) unless stated otherwise

Characteristic SAPT (n=433) DAPT (n=437)
Patient characteristic
Age (years) 59.8±10.7 60.2±10.3
Male 337 (78%) 332 (76%)
Body mass index 27.8±4.3 27.9±4.5
Medical history
Previous coronary artery bypass graft 8 (2%) 2 (0.5%)
Previous percutaneous coronary intervention 29 (7%) 18 (4%)
Previous myocardial infarction 26 (6%) 20/436 (5%)
Stroke or transient ischaemic attack 14 (3%) 8/436 (2%)
Peripheral arterial disease 16 (4%) 9/436 (2%)
Congestive heart failure 16 (4%) 19/436 (4%)
Risk factors
Diabetes mellitus 54 (13%) 61 (14%)
Hypertension 193 (45%) 195/436 (45%)
Dyslipidaemia 120 (28%) 125/436 (29%)
Current smoker 218/431 (51%) 205 (47%)
Family history of coronary artery disease 143/431 (33%) 144/436 (33%)
Drugs at start of study
P2Y12 inhibitors:
 Clopidogrel 180 (42%) 182 (42%)
 Prasugrel 128 (29%) 132 (30%)
 Ticagrelor 125 (29%) 123 (28%)
Percutaneous coronary intervention
Thrombolysis in myocardial infarction flow:
 Baseline <3 355/432 (82%) 355 (81%)
 After PCI 3 411 (95%) 421/436 (97%)
Infarct related artery:
 Left anterior descending 169 (39%)* 188 (43%)
 Right coronary artery 175 (41%) 179 (41%)
 Right circumflex artery 89 (21%) 70 (16%)
Lesion type culprit:
 B2 158/428 (37%) 158/433 (36%)
 C 108/428 (25%) 101/433 (24%)
Stent type culprit:
 Zotarolimus-eluting stent 400/432 (93%) 407/436 (93%)
 Other 32/432 (7%) 29/436 (7%)
Index procedure:
 Treated lesions 1.09±0.3 1.10±0.3
 Treated vessels 1.08±0.3 1.07±0.3
 Stents 1.42±0.8 1.48±0.8
 Total stent length (mm) 28.5±16 29.8±16
Minimum stent diameter (mm):
 <3 189/613 (31%) 178/645 (28%)
 ≥3 424/613 (69%) 467/645 (73%)
Non-culprit lesion intervention 54 (12.5%) 62 (14%)
*

One patient had left main as infarct related artery.

One patient received plain old balloon angioplasty without additional stenting.

Total is number of stents used during index procedure.